A Study of BEBT-908 in Combination With Chemotherapy in Patients With Previously Untreated Peripheral T-Cell Lymphoma (PTCL)

NCT07676175 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Previously Untreated Peripheral T-Cell Lymphoma

Interventions

DRUG: Ifupinostat Hydrochloride for Injection
DRUG: Cyclophosphamide for Injection
DRUG: Doxorubicin Hydrochloride for Injection
DRUG: Vincristine Sulfate for Injection
DRUG: Prednisone Acetate Tablets

Sponsor

BeBetter Med Inc

Collaborators

[object Object]
[object Object]